China SXT Pharmaceuticals Completes $12 Million Direct Offering
China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) has finalized a $12 million registered direct offering facilitated by Univest Securities. This capital markets event provides the company with additional funding through the direct sale of securities.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai